Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna IntHout

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
BMC Cancer|January 16, 2014
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled studyRafli van de Laar, Petra L M Zusterzeel, Toon Van Gorp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2022
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-AnalysisMiranda P Steenbeek, Majke H D van Bommel, Johan Bulten, et al.
Gynecologic Oncology|August 30, 2021
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategyMiranda P Steenbeek, Majke H D van Bommel, Marline G Harmsen, et al.
Human Pathology|August 21, 2021
Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panelNicole C M Visser, Anneke A M van der Wurff, Joanna IntHout, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2022
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H D van Bommel, Miranda P Steenbeek, Joanna IntHout, et al.
Journal of the National Cancer Institute|April 9, 2026
Menopause-related quality of life five years after salpingectomy with delayed oophorectomy versus Salpingo-OophorectomyTamar A Gootzen, Rosella Pmg Hermens, Marleen Mhj van Gelder, et al.
JAMA Oncology|June 3, 2021
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled TrialMiranda P Steenbeek, Marline G Harmsen, Nicoline Hoogerbrugge, et al.
Environment International|December 18, 2025
MATES: A tool for appraising the completeness with which a meta-analysis has been reportedKyle Morrison, Patrice Pottier, Pietro Pollo, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 17, 2025
Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference TrialMajke H D Van Bommel, Miranda P Steenbeek, Joanna Inthout, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
BMC Cancer|January 16, 2014
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled studyRafli van de Laar, Petra L M Zusterzeel, Toon Van Gorp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2022
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-AnalysisMiranda P Steenbeek, Majke H D van Bommel, Johan Bulten, et al.
Gynecologic Oncology|August 30, 2021
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategyMiranda P Steenbeek, Majke H D van Bommel, Marline G Harmsen, et al.
Human Pathology|August 21, 2021
Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panelNicole C M Visser, Anneke A M van der Wurff, Joanna IntHout, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2022
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H D van Bommel, Miranda P Steenbeek, Joanna IntHout, et al.
Journal of the National Cancer Institute|April 9, 2026
Menopause-related quality of life five years after salpingectomy with delayed oophorectomy versus Salpingo-OophorectomyTamar A Gootzen, Rosella Pmg Hermens, Marleen Mhj van Gelder, et al.
JAMA Oncology|June 3, 2021
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled TrialMiranda P Steenbeek, Marline G Harmsen, Nicoline Hoogerbrugge, et al.
Environment International|December 18, 2025
MATES: A tool for appraising the completeness with which a meta-analysis has been reportedKyle Morrison, Patrice Pottier, Pietro Pollo, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 17, 2025
Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference TrialMajke H D Van Bommel, Miranda P Steenbeek, Joanna Inthout, et al.
Pageof 12